Genpact (G) EBITDA (2009 - 2026)

Genpact has reported EBITDA for 18 years, with the latest figure at $192.9 million in Q2 2026.

• On a quarterly basis, EBITDA rose 7.55% year-over-year to $192.9 million in Q2 2026; TTM through Jun 2026 was $778.6 million, a 5.95% increase from a year earlier, with the FY2025 full-year figure at $750.2 million, up 6.86% from the prior year.
• EBITDA was $192.9 million for Q2 2026 at Genpact, down from $198.6 million in the prior quarter.
• The five-year high for EBITDA was $198.6 million in Q1 2026, with the low at $109.7 million in Q2 2022.
• Average EBITDA over 5 years is $165.4 million, with a median of $168.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA retreated 19.88% in 2022, then soared 43.43% in 2023.
• Over 5 years, EBITDA stood at $127.8 million in 2022, then increased by 27.38% to $162.7 million in 2023, then increased by 16.86% to $190.2 million in 2024, then climbed by 2.78% to $195.5 million in 2025, then retreated by 1.29% to $192.9 million in 2026.
• The last three EBITDA figures came in at $192.9 million (Q2 2026), $198.6 million (Q1 2026), and $195.5 million (Q4 2025), per Business Quant data.